Page last updated: 2024-08-21

pyrazines and Drug Withdrawal Symptoms

pyrazines has been researched along with Drug Withdrawal Symptoms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fayad, L; Fowler, N; Jain, P; Kanagal-Shamanna, R; Medeiros, LJ; Nastoupil, L; Oki, Y; Romaguera, J; San Lucas, FA; Wang, M; Westin, JR	1
Bourge, R; Carson, P; Feldman, AM; Holubkov, R; Jaski, B; Loftus, S; Soran, O; White, BG; Young, JD	1
Bardag-Gorce, F; French, BA; French, SW; Li, J	1

Trials

1 trial(s) available for pyrazines and Drug Withdrawal Symptoms

Article	Year
Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group. Journal of cardiac failure, 1999, Volume: 5, Issue:3 Topics: Cardiotonic Agents; Cause of Death; Chronic Disease; Disease Progression; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Pyrazines; Quinolines; Retrospective Studies; Substance Withdrawal Syndrome; Survival Rate	1999

Article

Year

Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group.

Journal of cardiac failure, 1999, Volume: 5, Issue:3

Topics: Cardiotonic Agents; Cause of Death; Chronic Disease; Disease Progression; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Pyrazines; Quinolines; Retrospective Studies; Substance Withdrawal Syndrome; Survival Rate

1999

Other Studies

2 other study(ies) available for pyrazines and Drug Withdrawal Symptoms

Article	Year
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors. British journal of haematology, 2018, Volume: 182, Issue:5 Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Benzamides; Disease Progression; Drug Resistance; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Mutation; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazines; Pyrazoles; Pyrimidines; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome	2018
Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341. Free radical biology & medicine, 2002, Jan-01, Volume: 32, Issue:1 Topics: Animals; Boronic Acids; Bortezomib; Chymases; Cytochrome P-450 CYP2E1; Ethanol; Liver; Male; Protease Inhibitors; Pyrazines; Rats; Rats, Wistar; Serine Endopeptidases; Substance Withdrawal Syndrome	2002

Article

Year

Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.

British journal of haematology, 2018, Volume: 182, Issue:5

Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Benzamides; Disease Progression; Drug Resistance; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Mutation; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazines; Pyrazoles; Pyrimidines; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome

2018

Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341.

Free radical biology & medicine, 2002, Jan-01, Volume: 32, Issue:1

Topics: Animals; Boronic Acids; Bortezomib; Chymases; Cytochrome P-450 CYP2E1; Ethanol; Liver; Male; Protease Inhibitors; Pyrazines; Rats; Rats, Wistar; Serine Endopeptidases; Substance Withdrawal Syndrome

2002